Skip to main content

Find Clinical Trials

Home
Conditions
Lipid Metabolism, Inborn Errors

Clinical trial condition

Lipid Metabolism, Inborn Errors

Explore clinical trials studying Lipid Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

833 public trials 155 recruiting studies

Refine in advanced search Browse all conditions

Lipid Metabolism, Inborn Errors trial results

Completed

Evaluation of Non-invasive Measurements of Atherosclerosis in Cardiovascular Risk Stratification

NCT01555294

Conditions: Cardiovascular Disease, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations: Radboud University Nijmegen Medical Centre, Department of General Internal Medicine, Division of Vascular Medicine Nijmegen, Netherlands

View Trial Details

Completed

Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism

NCT00465751

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Combined Hyperlipidemia, +16 more
Locations: University Hospital Basel Basel, Switzerland

View Trial Details

Completed

Pyrimethamine as a Treatment for Late-Onset GM2-gangliosidosis (Tay-Sachs and Sandhoff Disease)

NCT01102686

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +17 more
Locations: The Hospital for Sick Children Toronto, Ontario, Canada

View Trial Details

Completed

Belgian Screening Project for the Detection of Anderson-Fabry Disease in Hypertrophic Cardiomyopathy

NCT01198899

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +26 more
Locations: AZ Imelda Bonheiden, Belgium

AZ Sint-Blasius Dendermonde, Belgium

AZ Sint-Lucas Ghent, Belgium

Maria Middelares Ghent, Belgium

View Trial Details

Completed

Understanding the Genetic Basis of Familial Combined Hyperlipidemia in Mexican Individuals

NCT00365235

Conditions: Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Coronary Disease, +12 more
Locations: Instituto Nacional De Ciencias Medicas y Nutricion Mexico City, Mexico

View Trial Details

Completed

Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fed Conditions

NCT01286701

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Anapharm Inc. Québec, Canada

View Trial Details

Completed

Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions

NCT01505998

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Fed, +9 more
Locations: Vimta Labs Ltd. Hyderabad, A.P, India

View Trial Details

Completed

Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed Study

NCT01503424

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Fed, +9 more
Locations: Lambda Therapeutic Research Ltd., Ahmedabad, Gujarat, India

View Trial Details

Completed

Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition

NCT01503450

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Fed, +9 more
Locations: Wellquest Clinical Research Mumbai, Maharashtra, India

View Trial Details

Completed

Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)

NCT01279590

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +20 more
Locations: Furiex research site Anniston, Alabama, United States

Furiex research site Phoenix, Arizona, United States

Furiex research site Phoenix, Arizona, United States

Furiex research site Huntington Park, California, United States

View all 67 locations

View Trial Details